An intervention to improve the quality of antenatal care in Ermera municipality in Timor-Leste

ISRCTN ISRCTN10953598
DOI https://doi.org/10.1186/ISRCTN10953598
Submission date
27/05/2022
Registration date
31/05/2022
Last edited
19/12/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Most maternal and newborn deaths occurred in low- and middle-income countries, and most of these were preventable with appropriate antenatal care, deliveries with skilled birth attendants and postnatal care. These three components are usually referred to as Continuum of Care (CoC), and the effective CoC would reduce preventable child and maternal deaths. However, the increase of CoC is challenging in Timor-Leste, and the inadequate use of health services for pregnant women are the key determinants of maternal deaths. This study aims to assess the effectiveness of the intervention on the quality of care of antenatal care to increase CoC in Ermera municipality in Timor-Leste. Ermera has been selected as the research field due to the poorer coverage of maternal and newborn health services and the higher maternal, fetal and neonatal deaths cases than the other municipalities.

Who can participate?
The eligible participants are women who have delivered between 1 January 2020 and 31 December 2020 for the baseline period and between 1 June 2022 and 31 October 2022 for the follow-up period.

What does the study involve?
This study has two interventions. One is the ultrasound scan at least once during the pregnancy. The other is a health promotion card called the CoC card used from pregnancy to postpartum care and the ultrasound in the Guisarudu area. Researchers and the experts developed both interventions before the implementation as part of the project of the Non-profit Organization ‘Chikyu-no-Stage (English: Frontline)’. Health units will be allocated to carry out the intervention or to serve as a control (standard practice). The intervention will be used in health units from three municipalities Hatolia, Guisarudu, and Gleno. Health units from the rest of the area: Letefoho, Atsabe, Railaco, and Ermera will serve as controls.

What are the possible benefits and risks of participating?
Participants may benefit from this study due to the high quality of care. No risks are anticipated.

Where is the study run from?
Department of Community and Global Health, The University of Tokyo (Japan)

When is the study starting and how long is it expected to run for?
From April 2020 to November 2022

Who is funding the study?
Investigator-initiated and funded

Who is the main contact?
Kayono Nakajima, kayono714@gmail.com

Contact information

Ms Kayono Nakajima
Principal Investigator

5th floor, Medical Bldg. No 3
7-3-1 Hongo
Bunkyo-ku
Tokyo
1130033
Japan

ORCiD logoORCID ID 0000-0001-7682-2930
Phone +673-7706-5147
Email kayono714@gmail.com

Study information

Study designType 2 implementation-effectiveness hybrid quasi-experimental non-randomized trial
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital
Study typePrevention
Participant information sheet 41835_PIS_English.pdf
Scientific titleEffectiveness of Quality Maternal and Newborn Health Care for Improving Continuum of Care and Maternal Satisfaction in Timor-Leste: A Type 2 Implementation-effectiveness Hybrid Quasi-experimental Trial
Study objectives1. The quality of antenatal care in Ermera municipality is likely to influence the uptake of three key maternal and newborn health services
2. The planned intervention (ultrasound and Continuum of Care card) increases the Quality of Care of antental care
3. The improved Quality of Care through the intervention affects the uptake of continuity of maternal and newborn health services and maternal satisfaction
Ethics approval(s)1. Approved 16/09/2020, Graduate School of Medicine and Faculty of Medicine The University of Tokyo Ethics Committee (7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; +81-03-5841-0818; ethics@m.u-tokyo.ac.jp), ref: 2020184NI
2. Approved 10/5/2021, the Institute National of Health-Research Ethics & Technical Committee (Rua de Comoro, Dili, Timor-Leste; +671-3331-0099; no email address available), ref: 351/MS-INS/GDE/V/2021
Health condition(s) or problem(s) studiedPregnancy
InterventionThis study has two interventions. One is the ultrasound implementation during antenatal care, and the other is a health promotion card called the Continuum of Care card. This study developed ultrasound training for health workers and will implement ultrasound scans at least once during the pregnancy for all pregnant women in the intervention area. We also developed the Continuum of Care card with the expert who implemented the Continuum of Care card in Ghana. It will be used from pregnancy to postpartum care in addition to the ultrasound in the one Community Health Centre covered area. Pregnant women in the control area receive only essential antenatal care.
Intervention typeBehavioural
Primary outcome measureContinuum of Care completion level from pregnancy to delivery measured using surveys at baseline and at endline
Secondary outcome measures1. Continuum of Care completion level from pregnancy to postnatal period measured using surveys at baseline and at endline
2. Completion of recommended four antenatal care measured using surveys at baseline and at endline
3. Coverage of institutional delivery measured using surveys at baseline and at endline
4. Quality of Care level (total of 16 points for the essential antenatal care received, a total of 7 points for the health education received, and a total of 18 points for the experience of care) measured using surveys at baseline and at endline
5. Maternal satisfaction level (total 13 points) measured using surveys at baseline and at endline
6. Selected Quality of Care health outcome (perinatal mortality rate, stillbirth rate, maternal mortality rate) measured using surveys at baseline and at endline
Overall study start date01/04/2020
Completion date15/11/2022

Eligibility

Participant type(s)Patient
Age groupOther
SexFemale
Target number of participants1,222
Total final enrolment1286
Key inclusion criteria1. Pregnant women between 12 and 28 weeks of gestation in April 2022 (delivery between 1 May 2022 and 26 October 2022) for the follow-up data collection and women who delivered between 1 January 2020 and 31 December 2020 for the baseline data collection
2. Aged between 15 and 49 years
3. Living in the Ermera municipality
4. Receiving care at a participating health facility
Key exclusion criteriaWomen who did not receive antenatal care at a health facility
Date of first enrolment01/07/2021
Date of final enrolment10/11/2022

Locations

Countries of recruitment

  • Timor-Leste

Study participating centres

Guisarudu Community Health Centre
Fatobolo, Hatolia B
Ermera
-
Timor-Leste
Hatolia Community Health Centre
Hatolia villa, Hatolia A
Ermera
-
Timor-Leste
Gleno Community Health Centre
Gleno, Ermera
Ermera
-
Timor-Leste

Sponsor information

University of Tokyo
University/education

5th floor, Medical Bldg. No 3
7-3-1 Hongo
Bunkyo-ku
Tokyo
113-0033
Japan

Phone +81-3-3812-2111
Email ich@m.u-tokyo.ac.jp
Website http://www.ich.m.u-tokyo.ac.jp/en/map.html
ROR logo "ROR" https://ror.org/057zh3y96

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date01/04/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryPublished as a supplement to the results publication
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal.
IPD sharing planThe datasets generated and/or analysed during the current study will be published as a supplement to the subsequent results publication.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet English language 30/05/2022 No Yes
Participant information sheet Tetun language 30/05/2022 No Yes
Protocol file version 7 20/04/2022 30/05/2022 No No
Basic results 19/12/2022 No No

Additional files

41835_PIS_Tetun.pdf
Tetun language
41835_PIS_English.pdf
English language
41835_Protocol_v7_20Apr22.pdf
ISRCTN10953598_BasicResults.pdf

Editorial Notes

19/12/2022: The following changes have been made:
1. A basic results summary has been uploaded.
2. The final enrolment number has been added from the basic results summary.
30/05/2022: Trial’s existence confirmed by the Graduate School of Medicine and Faculty of Medicine, The University of Tokyo Ethics Committee.